Barbara Cebula-Obrzut Selected Research

Barbara Cebula-Obrzut Research Topics

Disease

11	Neoplasms (Cancer) 09/2023 - 10/2011
8	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 09/2023 - 10/2012
5	Breast Neoplasms (Breast Cancer) 12/2018 - 10/2011
3	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 08/2023 - 12/2013
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 02/2015 - 10/2010
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 10/2017 - 01/2014
2	Multiple Myeloma 10/2014 - 09/2013
2	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 07/2014 - 09/2013
1	Hematologic Neoplasms (Hematological Malignancy) 08/2015
1	Burkitt Lymphoma (Burkitt's Lymphoma) 10/2014
1	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 01/2014
1	Carcinogenesis 01/2014
1	Lymphoma (Lymphomas) 09/2013
1	Necrosis 06/2013
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 03/2013
1	Disease Progression 03/2013
1	Essential Thrombocythemia 12/2012
1	Common Variable Immunodeficiency 01/2011
1	Infections 01/2011

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 03/2017 - 10/2010
3	Clofarabine (Clolar)FDA Link 12/2018 - 01/2014
3	Interleukin-10 (Interleukin 10)IBA 10/2017 - 12/2012
2	retinoic acid receptor betaIBA 12/2018 - 01/2014
2	PhytochemicalsIBA 12/2018 - 01/2015
2	Toll-Like Receptors (Toll-Like Receptor)IBA 10/2017 - 01/2014
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2015 - 03/2013
2	Rituximab (Mabthera)FDA Link 12/2014 - 10/2012
2	ranpirnase (Pannon)IBA 07/2014 - 12/2013
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2013 - 12/2012
1	Sialic Acid Binding Ig-like Lectin 2IBA 09/2023
1	Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA 09/2023
1	Surface Antigens (Surface Antigen)IBA 09/2023
1	MelatoninIBA 08/2023
1	Doxorubicin (Adriamycin)FDA LinkGeneric 08/2023
1	Dexamethasone (Maxidex)FDA LinkGeneric 08/2023
1	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 12/2018
1	TeaIBA 12/2018
1	2'-deoxyadenosineIBA 12/2018
1	PolyphenolsIBA 12/2018
1	Phytoestrogens (Phytoestrogen)IBA 12/2018
1	Therapeutic UsesIBA 12/2018
1	GenisteinIBA 12/2018
1	Catechin (Z 7300)IBA 12/2018
1	NucleosidesIBA 12/2018
1	Interleukin-6 (Interleukin 6)IBA 10/2017
1	triphenylmethaneIBA 07/2016
1	honokiolIBA 07/2016
1	CytokinesIBA 08/2015
1	Programmed Cell Death 1 ReceptorIBA 08/2015
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 08/2015
1	CTLA-4 AntigenIBA 08/2015
1	Jagged-1 ProteinIBA 02/2015
1	Cisplatin (Platino)FDA LinkGeneric 01/2015
1	Inhibitor of Apoptosis ProteinsIBA 01/2015
1	sulforaphaneIBA 01/2015
1	SurvivinIBA 01/2015
1	AngiopoietinsIBA 01/2015
1	CaspasesIBA 12/2014
1	Bendamustine Hydrochloride FDA Link 12/2014
1	SMIP-016IBA 10/2014
1	ofatumumab FDA Link 10/2014
1	Ribonucleases (Ribonuclease)IBA 07/2014
1	DNA (Deoxyribonucleic Acid)IBA 01/2014
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2014
1	MethyltransferasesIBA 01/2014
1	ElementsIBA 01/2014
1	fludarabineIBA 01/2014
1	Adenosine (Adenocard)FDA LinkGeneric 01/2014
1	TensinsIBA 01/2014
1	Cladribine FDA LinkGeneric 06/2013
1	IRS 954IBA 06/2013
1	Toll-Like Receptor 7IBA 06/2013
1	Toll-Like Receptor 9IBA 06/2013
1	Monoclonal AntibodiesIBA 03/2013
1	Bevacizumab (Avastin)FDA Link 03/2013
1	bcl-2-Associated X Protein (bcl 2 Associated X Protein)IBA 10/2011
1	Caspase 3 (Caspase-3)IBA 10/2011
1	Polysaccharides (Glycans)IBA 01/2011
1	Intravenous Immunoglobulins (IVIG)FDA Link 01/2011
1	VaccinesIBA 01/2011
1	Staphylococcal Protein A (Protein A)IBA 10/2010

Therapy/Procedure

4	Therapeutics 01/2015 - 01/2011
1	VAP-cyclo protocol 12/2013
1	Hematopoietic Stem Cell Transplantation 09/2013
1	Drug Therapy (Chemotherapy) 09/2013